New on SHM’s Learning Portal: Preventing Stoke in Nonvalvular AFib Patients

Each day, hospitalists take a leading role in overseeing and co-managing anticoagulant use in patients, including those with nonvalvular atrial fibrillation (NVAF) who are at risk for stroke. It’s critical for hospitalists to be able to apply treatment plans using appropriate anticoagulant therapy during the patient’s hospital stay as well as at discharge. This requires hospitalists to have the ability to understand and apply current standards of care for the newer anticoagulants.

The interactive video case module “Appropriate Use of Targeted Oral Anticoagulants to Prevent Stroke in Patients with Nonvalvular Atrial Fibrillation” evaluates the current guidelines and scientific evidence regarding oral anticoagulation for stroke prevention in patients with NVAF. The activity includes thorough discussions on initial management of patients with NVAF, appropriate situations for oral anticoagulation in the presence of NVAF, appropriate choice of oral anticoagulant, reversal of oral anticoagulation, as well as guidelines for oral anticoagulation and stroke prevention in NVAF patients and in special-population NVAF patients.

This free module offers up to 1.0 AMA PRA Category 1 Credit and can be found at www.shmlearningportal.org under “SHM Consults.”

Each day, hospitalists take a leading role in overseeing and co-managing anticoagulant use in patients, including those with nonvalvular atrial fibrillation (NVAF) who are at risk for stroke. It’s critical for hospitalists to be able to apply treatment plans using appropriate anticoagulant therapy during the patient’s hospital stay as well as at discharge. This requires hospitalists to have the ability to understand and apply current standards of care for the newer anticoagulants.

The interactive video case module “Appropriate Use of Targeted Oral Anticoagulants to Prevent Stroke in Patients with Nonvalvular Atrial Fibrillation” evaluates the current guidelines and scientific evidence regarding oral anticoagulation for stroke prevention in patients with NVAF. The activity includes thorough discussions on initial management of patients with NVAF, appropriate situations for oral anticoagulation in the presence of NVAF, appropriate choice of oral anticoagulant, reversal of oral anticoagulation, as well as guidelines for oral anticoagulation and stroke prevention in NVAF patients and in special-population NVAF patients.

This free module offers up to 1.0 AMA PRA Category 1 Credit and can be found at www.shmlearningportal.org under “SHM Consults.”

Each day, hospitalists take a leading role in overseeing and co-managing anticoagulant use in patients, including those with nonvalvular atrial fibrillation (NVAF) who are at risk for stroke. It’s critical for hospitalists to be able to apply treatment plans using appropriate anticoagulant therapy during the patient’s hospital stay as well as at discharge. This requires hospitalists to have the ability to understand and apply current standards of care for the newer anticoagulants.

The interactive video case module “Appropriate Use of Targeted Oral Anticoagulants to Prevent Stroke in Patients with Nonvalvular Atrial Fibrillation” evaluates the current guidelines and scientific evidence regarding oral anticoagulation for stroke prevention in patients with NVAF. The activity includes thorough discussions on initial management of patients with NVAF, appropriate situations for oral anticoagulation in the presence of NVAF, appropriate choice of oral anticoagulant, reversal of oral anticoagulation, as well as guidelines for oral anticoagulation and stroke prevention in NVAF patients and in special-population NVAF patients.

This free module offers up to 1.0 AMA PRA Category 1 Credit and can be found at www.shmlearningportal.org under “SHM Consults.”